adr_usa_0438|IPHA|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
adr_usa_0438|IPHA|1|Innate Pharma SA Total Current Assets (Quarterly) (USD)|Innate Pharma SA Cash and Short Term Investments (Quarterly) (USD)|Innate Pharma SA Inventories (Quarterly) (USD)|Innate Pharma SA Net PP&E (Quarterly) (USD)|Innate Pharma SA Goodwill and Intangibles (Quarterly) (USD)|Innate Pharma SA Total Liabilities (Quarterly) (USD)|Innate Pharma SA Total Current Liabilities (Quarterly) (USD)|Innate Pharma SA Total Long Term Liabilities (Quarterly) (USD)|Innate Pharma SA Total Deposits (Quarterly) (USD)|Innate Pharma SA Book Value (Quarterly) (USD)|Innate Pharma SA Retained Earnings (Quarterly) (USD)|Innate Pharma SA Treasury Stock (Quarterly) (USD)|Innate Pharma SA EV to Revenues|Innate Pharma SA EV to Earnings|Innate Pharma SA EV to Free Cash Flow|Innate Pharma SA EV to Assets (Quarterly)|Innate Pharma SA PS Ratio|Innate Pharma SA PE Ratio|Innate Pharma SA Price to Book Value|Innate Pharma SA PEG Ratio|Innate Pharma SA Debt to Equity Ratio|Innate Pharma SA Dividend Yield|Innate Pharma SA Shareholder Yield (TTM)|Innate Pharma SA Percent of Shares Outstanding Short|Innate Pharma SA Total Receivables (Quarterly) (USD)|Innate Pharma SA Total Payables (Quarterly) (USD)|Innate Pharma SA Total Capital Stock (Quarterly) (USD)|Innate Pharma SA Return on Invested Capital|Innate Pharma SA Quality Ratio Score|Innate Pharma SA Momentum Score|Innate Pharma SA Beta (1Y)|Innate Pharma SA Sustainable Growth Rate (TTM)|Innate Pharma SA Institutional Investor Ownership Percentage|Innate Pharma SA Average Diluted Shares Outstanding (Quarterly)|Innate Pharma SA Total Employees (Annual)|Innate Pharma SA EPS Diluted (Quarterly) (USD)|Innate Pharma SA SG&A Expense (Quarterly) (USD)|Innate Pharma SA Shares Outstanding|Innate Pharma SA Repurchase of Capital Stock (Quarterly) (USD)|Innate Pharma SA Ordinary Shares Number (Quarterly)|Innate Pharma SA Payout Ratio|Innate Pharma SA Quick Ratio (Quarterly)|Innate Pharma SA Normalized Diluted EPS (Quarterly) (USD)|Innate Pharma SA Stock Buybacks (Quarterly) (USD)|Innate Pharma SA Effective Tax Rate (TTM)|Innate Pharma SA Return on Equity|Innate Pharma SA Net Income (TTM) (USD)|Innate Pharma SA Revenue (TTM) (USD)|Innate Pharma SA Dividend Per Share (Quarterly) (USD)|Innate Pharma SA Revenue (Quarterly) (USD)|Innate Pharma SA Gross Profit (Quarterly) (USD)|Innate Pharma SA Pre-Tax Income (Quarterly) (USD)|Innate Pharma SA Net Income (Quarterly) (USD)|Innate Pharma SA Net Interest Income (Quarterly) (USD)|Innate Pharma SA Price (USD)|Innate Pharma SA Total Return Price (USD)|Innate Pharma SA Enterprise Value (USD)|Innate Pharma SA 30-Day Average Daily Volume|Innate Pharma SA 1 Year Price Returns (Daily)|Innate Pharma SA Short Interest|Innate Pharma SA PE Ratio (Forward)|Innate Pharma SA PE Ratio (Forward 1y)|Innate Pharma SA PS Ratio (Forward)|Innate Pharma SA PS Ratio (Forward 1y)|Innate Pharma SA Quarterly EPS Estimates (USD)|Innate Pharma SA Quarterly Revenue Estimates (USD)|Innate Pharma SA Quarterly EPS Surprise|Innate Pharma SA Quarterly Revenue Surprise|Innate Pharma SA Quarterly Actual EPS (USD)|Innate Pharma SA Quarterly Actual Revenue (USD)|Innate Pharma SA Revenue Estimates for Current Fiscal Year (USD)|Innate Pharma SA Revenue Estimates for Next Fiscal Year (USD)|Innate Pharma SA Price Target (USD)|Innate Pharma SA Consensus Recommendation|Innate Pharma SA Price Target Num Estimates|Innate Pharma SA EPS Estimates for Current Fiscal Year (USD)|Innate Pharma SA EPS Estimates for Next Fiscal Year (USD)|Innate Pharma SA Research and Development Expense (Quarterly) (USD)|Innate Pharma SA Reconciled Depreciation (Quarterly) (USD)|Innate Pharma SA Non-Operating Interest Expense (Quarterly) (USD)|Innate Pharma SA Land and Improvements (Quarterly) (USD)|Innate Pharma SA Buildings and Improvements (Quarterly) (USD)|Innate Pharma SA Other Properties (Quarterly) (USD)|Innate Pharma SA Machine, Furniture & Equipment (Quarterly) (USD)||
adr_usa_0438|IPHA|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
adr_usa_0438|IPHA|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|monthly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
adr_usa_0438|IPHA|5|182.565217391|182.565217391||182.565217391|182.533333333|182.565217391|182.565217391|182.565217391||182.565217391|182.565217391||1.44915254237|182.333333333|1.44915254237|182.333333333|1.44915254237|1.48|1.44915254237||182.565217391|1.44915254237|182.333333333|15.2407407407|182.565217391|182.565217391|182.565217391|182.636363636||32.8461538462|30.4666666667|182.636363636|30.5||730.5|||110.224489796||182.565217391|182.565217391|182.565217391|||182.565217391|182.636363636|182.565217391|182.565217391|||||||1.44915254237|1.44915254237|1.44915254237|1.45098039216|1.44510385757|15.2407407407|||1.44712430427|1.44712430427|92|92|||||29.25|26.9454545455|41.45|14.8035714286|41.45|26.3870967742|27.2857142857|||||182.75|182.714285714|182.75||
adr_usa_0438|IPHA|6|23|23||23|15|23|23|23||23|23||590|3|590|3|590|50|590||23|590|3|54|23|23|23|22||13|15|22|14||6|||49||23|23|23|||23|22|23|23|||||||590|590|590|561|337|54|||539|539|1|1|||||36|55|20|56|20|31|28|||||4|21|4||
adr_usa_0438|IPHA|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
adr_usa_0438|IPHA|200609||||||||||||||||||||||||||||||||||||||22.8507||||||||||||||||||||||||||||||||||||||||||||||||
adr_usa_0438|IPHA|200612||||||||||||||||||||||||||||||||||||||24.9828||||||||||||||||||||||||||||||||||||||||||||||||
adr_usa_0438|IPHA|200706||||||||||||||||||||||||||||||||||||||25.165||||||||||||||||||||||||||||||||||||||||||||||||
adr_usa_0438|IPHA|200712||||||||||||||||||||||||||||||||||||||25.1703||||||||||||||||||||||||||||||||||||||||||||||||
adr_usa_0438|IPHA|200806||||||||||||||||||||||||||||||||||||||25.9123||||||||||||||||||||||||||||||||||||||||||||||||
adr_usa_0438|IPHA|200812|||||||||||||||||||||||||||||||||||89|||25.9123||||||||||||||||||||||||||||||||||||||||||||||||
adr_usa_0438|IPHA|200906||||||||||||||||||||||||||||||||||||||25.9123||||||||||||||||||||||||||||||||||||||||||||||||
adr_usa_0438|IPHA|200912|80.4604|70.3474||11.3585||24.4487|13.249|11.1998||67.3845|-90.4089||||||||||0.1603||||10.1115|11.9677|2.6198||||||||80|||36.637||36.637||6.0729|||||-20.6974|10.8097||||||||||||||||||||||||||||||||||||||
adr_usa_0438|IPHA|201006|58.2224|47.8628||9.3752||18.0803|8.9057|9.1747||49.5307|-76.8897||||||||||||||10.2373|7.9702|2.3038|-28.8599||||-31.5264|||81|||37.6868||37.6868||6.524||||-31.5264|-18.4296|6.9271||||||||||||||||||||||||||||||||||7.6266|-0.0024|2.3184||
adr_usa_0438|IPHA|201012|54.0815|45.9913||9.7553||19.2764|9.8071|9.4693||44.5749|-18.1646||||||||||0.1987||||8.0901||2.5056|-29.7636||||-33.387|||86|||37.687||37.687||5.5145||||-33.387|-17.9722|5.6552||||||||||||||||||||||||||||||||||||||
adr_usa_0438|IPHA|201106|48.8005|42.9301||9.8009||19.2428|11.4122|7.8306||40.8063|-118.5377||||||||||||||5.8704|8.3923|2.7275|-35.3381||||-37.6582|||78|||37.6868||37.6868||4.2762||||-37.6582|-16.9351|6.8777||||||||||||||||||||||||||||||||||||||
adr_usa_0438|IPHA|201112|68.6185|60.3688||8.3443||43.3718|20.0694|23.3024||34.4874|-108.4037||||||||||0.0909||||7.4972|7.5814|2.4403|-22.5072||||-24.7587||||||37.687||37.687||3.3816||||-24.7587|-9.8926|10.3264|||||||||||||||||||||||||||||||||||1.1671|||
adr_usa_0438|IPHA|201206|60.0326|46.95||8.5716||38.7764|22.0287|16.7477||30.6638|-106.8432|||||||||||||||20.4314|2.3438|-13.6348||||-14.038||||||37.6868||37.6868||2.1313||||-14.038|-4.9581|12.841||||||||||||||||||||||||||||||||||6.8934|1.1047|2.1473||
adr_usa_0438|IPHA|201212|54.2185|43.1347||9.0247||32.9712|20.3189|12.6524||30.8989|-115.1488||||||||||0.0321||||9.5604|8.6267|2.5088|-12.3479||||-12.878||||||37.936||37.936||2.5934||||-12.878|-4.1231|13.3903|||||||||||||||||||||||||||||||||||2.1821|||
adr_usa_0438|IPHA|201306|45.8025|32.2418||8.5169||26.5074|19.4866|7.0208||27.9958|-116.5028||||||||||0.029||||12.0997|7.9865|2.4854|-14.9811||||-15.2824||||||38.0606||38.0606||2.2755||||-15.2824|-4.5622|12.4235|||||||||||||||||||||||||||||||||||2.0227|||
adr_usa_0438|IPHA|201312|68.1459|57.0976||8.6415||21.536|12.8117|8.7243||55.6297|-124.2286||||||||||0.0405||||9.7517|10.2267|3.158|-9.6361||||-9.9771||||||45.7043||45.7043||5.2178||||-9.9771|-3.8087|16.724|||||||||||||||||||||||||||||||||||2.0216|||
adr_usa_0438|IPHA|201406|124.094|107.661||8.2595|8.6592|25.1672|17.3744|7.7929||115.9942|-135.0698||||||||||0.0176||||13.7167|15.5612|3.6127|-19.3016||||-19.7956||||||52.9418||52.9418||6.986||||-19.7956|-13.172|12.2105|||||||||||||||||||||||||||||||||||1.9223|||
adr_usa_0438|IPHA|201412|96.4474|84.1948||7.2122|6.5203|19.5341|13.1026|6.4315||90.7467|-133.1882||||||||||0.0201||||10.4395|11.4756|3.22|-28.6554||||-29.3239||||||52.9371||52.9371||7.2226||||-29.3239|-25.6458|1.2587|||||||||||||||||||||||||||||||||||1.745|||
adr_usa_0438|IPHA|201506|330.2551|312.8423||6.5232|5.3074|264.591|64.8666|199.7244||77.59|-130.6675||||||||||0.0217||||13.3302|11.2048|3.0014|-22.8896||||-23.3365||||||53.4974||53.4974||5.0284||||-23.3365|-22.1177|1.2823|||||||||||||||||||||||||||||||||||1.6476|||
adr_usa_0438|IPHA|201512|275.6494|257.9204||6.8922|10.64|255.7108|65.7762|189.9346||78.7909|-127.0754||||||||||0.0208||||10.8761|20.3693|2.9432|-8.8298||||-9.0136||||||53.8119||53.8119||4.0865||||-9.0136|-7.425|19.6056|||||||||||||||||||||||||||||||||||2.1221|||
adr_usa_0438|IPHA|201606|250.133|226.8362||8.6985|11.1178|237.0975|88.1407|148.9568||76.9784|-132.819||||||||||0.0217||||14.5961|15.1523|2.9978|-2.6914||||-2.7489||||||53.8771||53.8771||2.7392||||-2.7489|-2.1383|36.9943|||||||||||||||||||||||||||||||||||2.9266|||
adr_usa_0438|IPHA|201612|243.2293|208.9878||9.6138|9.5937|206.5775|80.8104|125.7672||91.0944|-109.5165||||||||||0.0165||||27.0147|21.4233|2.8501|16.0617||||16.375||||||53.9922||53.9922||2.9204|||2.3532|16.375|13.4746|61.4352|||||||||||||||||||||||||||||||||||5.4592|||
adr_usa_0438|IPHA|201706|223.9514|196.1674||11.2495|8.8312|203.0208|86.9703|116.0504||78.8278|-145.2266||||||||||0.0174||||20.0601|20.7991|3.0898|-10.3131||||-10.503||||||53.994||53.994||2.4862|||-3.9033|-10.503|-8.644|59.7278|||||||||||||||||||||||||||||||||||6.8293|||
adr_usa_0438|IPHA|201712|164.9839|139.2972||12.8716|55.4165|202.8297|88.6686|114.1611||103.1214|-182.3304||||||||||0.0331||||18.0963|29.581|3.4551|-59.252||||-60.6185||||||57.5815||57.5815||1.7751|||-0.7917|-60.6185|-55.1716|37.2233||||||||||||||||||||||||99.7479|||||||||||7.9204|||
adr_usa_0438|IPHA|201803||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||139.2991||||||||||||||
adr_usa_0438|IPHA|201806|141.7999|112.0148||12.3414|51.9173|160.4184|77.7158|82.7025||100.788|-173.6558||||||||||0.0112||||24.9903|30.3332|3.3299|-49.3895||||-50.4232||||||57.5815||57.5815||1.7629|||-0.0753|-50.4232|-47.5217|39.4637||||||||||||||||||||||||129.5851|||||||||||7.5373|||
adr_usa_0438|IPHA|201809||||||||||||||||||||||||||||||||||||||63.9141||||||||||||||||||||||||||||||||||117.608||||||||||||||
adr_usa_0438|IPHA|201812|365.6396|191.6387||11.6861|96.6927|324.8401|225.0475|99.7927||191.3058|-154.1874||||||||||0.0145||||167.7381|104.8442|3.657|1.9947||||2.0316||||||64.0253||64.0253||1.5969|||-17.4308|2.0316|2.6765|92.0132||||||||||||||||||||||||155.853|||||||||||6.9789|||
adr_usa_0438|IPHA|201903||||||||||||||||||||||||||||||||||||||64.0253|||||||||||||||||||||||||||||||||82.2176|104.8882||||||||||||||
adr_usa_0438|IPHA|201906|246.3629|187.5527||12.9595|99.9207|194.7556|107.5022|87.2534||206.0994|-138.3399||||||||||0.012||||50.31|32.0441|3.6418|21.1679||||21.4384||||||64.0253||64.0253||2.2126||||21.4384|35.6015|130.6132|||||||||||||||||||||||70.0762||||||||||||7.3086|||
adr_usa_0438|IPHA|201909|||||||||||||2.1586||-59.8108||2.8734|10.2874|2.266|||||0.0496||||||||||||||78.4919|||||||||||||||||5.95|5.95|281.938|51722.4||38947|||||0.05|27.4914|||||89.7623|126.5722|12.25|1.25|4|0.062|0.4703||||||||6.285|
adr_usa_0438|IPHA|201912|266.158|245.166||13.0746|108.6206|206.0497|136.4614|69.5883||243.5429|-174.378||3.6248|-12.2882|-8.2719|0.6225|5.6734|11.1174|2.084||0.0717||-15.4737|0.0503|14.7202|55.4529|4.4146|-10.2949||||-10.6596|||235|||78.8126||78.8126||1.9045||||-10.6596|-22.7743|77.2047|||||||6.44|6.44|279.8551|18581.6||39662|||4.8951|10.6902|-0.17|24.9805||||||136.3404||1.25||0.0553|-0.8617||||||6.6617||7.02|6.26
adr_usa_0438|IPHA|202003|||||||||||||3.8698||-8.831||5.8848||2.1617|||||0.0539||||||||||||||78.8797|||||||||||||||||6.68|6.68|298.7701|25813.2||42480|||5.0775|11.0886|||||||105.2614|95.9535|12|1.25|4|-0.1603|-0.7698||||||||7.6|6.5
adr_usa_0438|IPHA|202006|184.0961|166.1599||13.9841|107.0855|140.9234|92.611|48.3124||233.6659|-186.7548||7.5881|-8.0657|-3.8504|1.0557|9.7739||2.3129||0.0906||-14.658|0.0176|17.9362|29.8532|4.4379|-20.3046||||-21.5258||||||78.8983||78.8983||1.9878||||-21.5258|-49.0291|52.1154|||||||6.85|6.85|395.4553|8358.5||13851|||5.2124|11.3831|||||||102.1383|109.8571||1.25||0.1297|-0.6743||||||||6.0781|6.21
adr_usa_0438|IPHA|202009|||||||||||||3.0359||-1.5405||5.4791||1.2976|||||0.0287||||||3|0.4297||11.7884|||||78.9627|||||||||||||||||3.84|3.84|158.2164|11172.6333|-25.9696|22653|||2.9244|6.3864|||||||104.8151|78.4557|10.875|1.25|4|-0.024|-0.9697||||||||4.39|5.34
adr_usa_0438|IPHA|202012|213.3378|186.5074||14.3832|56.9336|186.2738|55.9484|130.3253||191.8442|-271.157||2.3933|-2.0661|-2.2563|0.4117|4.9632||1.6839||0.0997||-24.3443|0.03|17.0559|36.3306|4.8583|-31.1008||4|0.6031|-33.7857|11.3624||244|||78.9865||78.9865||3.6384||||-33.7857|-75.3481|65.0471|||||||4.09|4.09|155.6769|17859.4333|-36.4907|23719|||6.8043|4.7945|||||||105.8774|72.8919|6.4|2|5|-0.202|-1.2355||||||6.8583||4.09|4.59
adr_usa_0438|IPHA|202103|||||||||||||2.6594||-2.5071||5.2302||1.7742|||||0.0088||||||1|1.5415||11.624|||||78.9777|||||||||||||||||4.31|4.31|172.988|17273.5333|-35.479|6950|||7.1689|5.0514|||||||48.6578|91.699|7.3|2|5|-0.773|-0.906||||||||4.24|3.91
adr_usa_0438|IPHA|202106|154.3326|141.9956||12.9606|53.781|157.8646|50.7179|107.1467||158.9416|-290.5458||3.1691|-1.4865|-4.2819|0.4343|5.9859||1.6354||0.1236||-28.3965|0.0081|12.3382|20.2615|4.703|-43.0892||1|1.6427|-47.5075|11.4906|||||79.009||79.009||3.043||||-47.5075|-92.5528|43.4137|||||||3.29|3.29|137.5819|25019.8|-51.9708|6435|||5.4749|3.8578|||||||48.6624|89.2309|7.15|2|5|-0.7845|-0.905||||||||3.32|3.64
adr_usa_0438|IPHA|202109|||||||||||||8.4299||-11.3901||11.2258||3.0724|||||0.1738||||||2|-2.2197||12.4825||||||||||||||||||||||6.17|6.17|365.9719|4906500.4333|60.6771|137808|||10.2853|7.2473|||||||47.9802|64.2855|9.85|1.6|5|-0.579|-0.8525||||||||5.8|4.96
adr_usa_0438|IPHA|202112|||||||||||||5.4947||-7.4242||8.2966||2.2707|||||0.1344||||||3|-4.2423||13.1036||||||||||||||||||||||4.56|4.56|238.5472|103128.8667|11.4914|106572|||5.7712|5.6846|||||||54.5112|91.328|10.0625|1.6|4|-0.5915|-0.6085||||||||3.79|3.52